Graft materials for
POP(Pelvic organ prolapse) Grafts have been employed in repairing defects or
hernias throughout the body. Their purpose is to either completely replace the
weak tissue by spanning across that tissue or to provide a scaffold for
fibroblast infiltration. The patient’s own connective tissue may grow into the
graft, and if the graft is degradable, replace the graft as a supportive
structure. Graft materials include autologous tissues like cadaveric allografts
and fascia, dermis and other connective tissues, xenografts from animal sources, and various synthetic materials.
Julian first reported on
the use of synthetic mesh for cystocele repair in 1996.Recently a number of
prolapse repair mesh devices have been designed by different companies and
extensively marketed as a minimally invasive approach for pelvic floor repair. Each
of these prolapse repair mesh devices utilizes woven monofilament low-weight macroporous polypropylene
meshes with extension arms to permanently reinforce the pubocervical and the
rectovaginal fascia. Insertion techniques
are very similar and involve the use of especially shaped insertion needles to
anchor the mesh arms. The needle passage lies close to vessels, nerves and
organs of the pelvis and pelvic sidewall, with slight differences between
devices as to which structures are closest to the needle tracks.
Perigee and Apogee are
comprehensive, single-use needle suspension kits that provide a standardized
delivery method for mesh or graft-augmented repairs.
Perigee uses the transobturator technique for the
treatment of anterior prolapse;
Apogee uses a posterior vaginal and perianal approach for
the treatment of vault and posterior prolapse. These kits represent the “next generation” in vaginal prolapse repair
because they allow for safe, consistent, comprehensive treatment and offer
tension-free mesh or graft augmentation options to accommodate individual
patient pathologies. They allow pelvic organ prolapse to be repaired in a
minimally invasive manner with a short procedure time and the postoperative recovery
is also rapid.
Inclusion
criteria for Perigee or Apogee are
patients with symptomatic anterior or posterior vaginal wall prolapse
respectively with stage 3 or more as per the POPQ systems.
Exclusion
criteria for Apogee and Perigee are
patients with pelvic organ prolapse less than stage II (POPQ) or patients with
history of prior graft- augmented repair and patients with systemic or local
conditions that would preclude surgery or affect healing such as coagulation
disorders, infections, compromised immune response, vaginal bleeding,
uncontrolled diabetes, restricted leg motion (inability to conform to the
lithotomy position), history of pelvic cancer in previous six months, history
of radiation to the pelvic area.
APOGEE
SYSTEM -
o The Apogee kit includes
2 thin-profile, curved needles and 1 precut, large-pore polypropylene mesh
graft, approximately 5 cm by 13 cm, with 2 mesh arms.
o The kit can also be used
with a lyophilized porcine dermis graft.
o The Apogee kit enables
surgeons to repair multiple defects with one ready-to-use, preconfigured
system.
o Held in the 12 o’clock
position, the needle should be inserted into the incision and passed through
the ischiorectal fossa.
o Has a 2 point approach
advantages
of the APOGEE procedure —
o Minimally Invasive
o No abdominal incisions
(vs. Sacral Colpopexy) o Decreased risk of bleeding (vs. Sacro-Spinous ligament
fixation SSLF) o Decreased risk of nerve injury (vs. SSLF) o No general
anaesthesia required (vs. Sacral colpopexy)
o Decreased recovery period,
o Treats rectocele, enterocele and vault prolapse in one procedure
As compared to Apogee,
Perigee has a 4 point approach. Principle of PIVS remains the same and is
indicated for anterior wall defects.
o New minimally invasive
vaginal approach for Vault Prolapse, o Transobturator Approach
o For repair of anterior
vaginal wall defects (all central, lateral, proximal and distal defects) o
Provides Level 2 support o Four point fixation
COMPLICATIONS OF
THE APOGEE AND PERIGEE SYSTEMS (58,59)
Mesh exposure / vaginal
erosions — 0 — 25%
Dyspareunia — 2% - 69 %
Urinary symptoms — 3% -
23%
Constipation and Voiding
difficulties — 4.3% - 24%
Post operative infection —
2.3% - 31.5%
In 2008, FDA issued a
warning regarding the use of mesh for prolapse and incontinence repair , the
warning being repeated in 2011, although narrowing it to vaginal mesh used to
correct pelvic organ prolapse (not for anti-incontinence procedures or when
used abdominally). These warnings arose from concerns over mesh erosion through
vagina, pain, infection, bleeding, dyspareunia, organ perforation and urinary
problems. While many of these complications are common to all pelvic floor
repairs, mesh erosion and some type of organ perforation are surely unique to
mesh and trocars used for its placements.
No comments:
Post a Comment